Related Experiment Video
Updated: Feb 21, 2026

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
7.1K
Functional dyspepsia: New insights into the pathophysiology
Journal of Gastroenterology and Hepatology
|October 5, 2017
Summary
Functional dyspepsia pathogenesis is unclear, but visceral hypersensitivity is key. Motor issues and psychological factors may also play roles, though their significance is debated.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Visceral Pain Research
Background:
- The exact causes of functional dyspepsia (FD) are not fully understood.
- Emerging evidence suggests visceral hypersensitivity, characterized by reduced sensory thresholds in the stomach and small intestine, is a primary factor in FD pathogenesis.
- Other potential contributors include motor abnormalities and psychological influences, but their roles require further clarification.
Purpose of the Study:
- To explore the current understanding of functional dyspepsia pathogenesis.
- To highlight the role of gastroduodenal visceral hypersensitivity.
- To discuss other contributing factors and their controversial roles.
Main Methods:
- Review of existing literature on functional dyspepsia.
- Analysis of evidence supporting visceral hypersensitivity as a primary mechanism.
- Evaluation of data on motor abnormalities, psychological factors, H. pylori, and gastric acid.
Main Results:
- Gastroduodenal visceral hypersensitivity is increasingly recognized as a predominant factor in functional dyspepsia.
- Subgroups of patients exhibit motor abnormalities like delayed gastric emptying and small intestinal dysmotility, potentially secondary phenomena.
- The influence of psychological factors, Helicobacter pylori gastritis, and gastric acid sensitivity remains debated.
Conclusions:
- Visceral hypersensitivity is a central mechanism in functional dyspepsia.
- Motor dysfunctions and psychological factors may contribute but are often secondary.
- Further research is needed to clarify the roles of H. pylori and gastric acid in FD.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.3K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.3K
Peptic Ulcer Disease I: Introduction
917
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
917
Peptic Ulcer Disease II: Pathophysiology
2.3K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.3K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Gastritis-II: Pathophysiology
1.4K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.4K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
667
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
667

